Molecular Mechanisms of Liver Metastasis: Connecting Biology, Biomarkers, and Outcomes
Name
cells-15-00469.pdf
Size
151.38 KB
Format
Adobe PDF
Checksum (MD5)
6e550c78f246b3a9509d83f110ad7525
Author(s) • •
Wagner, Doris
Balzer, Felix
Margonis, Georgios Antonios
Date Issued
March 5, 2026
Journal
Cells
Publisher
Multidisciplinary Digital Publishing Institute
Citation
Wagner, Doris, Felix Balzer, and Georgios Antonios Margonis. 2026. "Molecular Mechanisms of Liver Metastasis: Connecting Biology, Biomarkers, and Outcomes" Cells 15, no. 5: 469.
Version
Final published version
Abstract
In our Special Issue titled “Molecular Mechanisms of Liver Metastases,” we aimed to attract articles that connect metastasis mechanisms and biomarkers with clinical disease characteristics and patient outcomes. Starting with the review paper by the Ohio State group, the authors provide valuable insight into the complex, multi-step molecular mechanisms underpinning liver metastasis [1]. Moving from pathogenesis to the prognostic and predictive role of clinically actionable proxies of tumor biology, the University of California, San Francisco (UCSF) group reviews current evidence on the prognostic and predictive relevance of key alterations—including RAS, BRAF, mismatch repair (MMR) genes, TP53, and SMAD4—in surgically treated colorectal liver metastases (CRLMs) [2]. For RAS and BRAF in particular—given the breadth of existing evidence—the authors emphasize the largest and/or the most recently published studies to provide the most robust and contemporary overview for readers.
MIT Department
Massachusetts Institute of Technology. Operations Research Center
Terms of Use
Creative Commons Attribution
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.3390/cells15050469